Literature DB >> 2420783

(2'-5') oligoadenylate synthetase in chicken embryo erythrocytes and immature red blood cells.

J Sokawa, Y Sokawa.   

Abstract

The appearance and induction of (2'-5')oligoadenylate synthetase (2-5A synthetase) in chicken embryo erythrocytes during development, and the activity and molecular size of this enzyme in immature red blood cells from anemic chickens were studied. Enzyme activity first appeared in the embryos on the 15th day of incubation, a marked increase being seen 1 or 2 days after hatching. In erythrocytes from early embryos without 2-5A synthetase activity, chicken interferon (5 IU/ml at most) induced the production of a large amount of the enzyme. In immature red blood cells from anemic chickens, only a small amount of 2-5A synthetase was detected in the nuclear fraction. The cytoplasmic fraction contained the smaller enzyme (about 45 kilodaltons), but the larger enzyme (85-120 kilodaltons) was scarcely detected in either fraction. The larger enzyme may be synthesized during the maturation of red blood cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420783     DOI: 10.1093/oxfordjournals.jbchem.a135450

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

1.  Molecular Cloning and Identification of the 2'-5' Oligoadenylate Synthetase 2 Gene in Chinese Domestic Pigs Through Bioinformatics Analysis, and Determination of Its Antiviral Activity Against Porcine Reproductive and Respiratory Syndrome Virus Infection.

Authors:  Ruining Wang; Hongfang Ma; Yinfeng Kang; Cunfa Li; Huawei Li; Erqin Zhang; Pengchao Ji; Jian He; Mengmeng Zhao
Journal:  Indian J Microbiol       Date:  2018-04-26       Impact factor: 2.461

Review 2.  Avian Interferons and Their Antiviral Effectors.

Authors:  Diwakar Santhakumar; Dennis Rubbenstroth; Luis Martinez-Sobrido; Muhammad Munir
Journal:  Front Immunol       Date:  2017-01-31       Impact factor: 7.561

Review 3.  The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.

Authors:  M R Player; P F Torrence
Journal:  Pharmacol Ther       Date:  1998-05       Impact factor: 12.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.